Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04292405 · ClinicalTrials.gov registry record
Accuracy of Cardiac Acoustic Biomarkers Recorded by the Wearable Cardioverter Defibrillator
A clinical trial, sponsored by Zoll Medical Corporation.
- Terminated
- Registry status
- 60
- Enrollment target
NCT04292405 is a clinical trial that was terminated before completion, run by Zoll Medical Corporation. The registered enrollment target is 60 participants.
The verdict
NCT04292405 was terminated before completion, sponsored by Zoll Medical Corporation.
- TERMINATED
- Registry status
- 60 participants
- Enrollment target
Study Summary
Evaluate data accuracy of cardiac acoustic biomarkers (CABs) recorded by the Wearable Cardioverter Defibrillator (WCD) as compared to the AUDICOR AM acoustic cardiography recorder.
Interventions
- DEVICE Wearable Cardioverter Defibrillator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2020-01-23 |
| Est. Completion | 2025-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04292405
The ClinicalTrials.gov registry entry for NCT04292405 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zoll Medical Corporation, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Wearable Cardioverter Defibrillator is the first listed.
NCT04292405 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04292405 about?
NCT04292405 is a clinical study titled "Accuracy of Cardiac Acoustic Biomarkers Recorded by the Wearable Cardioverter Defibrillator". Evaluate data accuracy of cardiac acoustic biomarkers (CABs) recorded by the Wearable Cardioverter Defibrillator (WCD) as compared to the AUDICOR AM acoustic cardiography recorder.
What is the current status of trial NCT04292405?
This trial is currently terminated. The enrollment target is 60 participants. The study started on 2020-01-23. Estimated completion is 2025-09-30.
What interventions are being tested in trial NCT04292405?
The interventions under investigation include: Wearable Cardioverter Defibrillator (DEVICE).
Who is sponsoring clinical trial NCT04292405?
This trial is sponsored by Zoll Medical Corporation, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.